Nothing Special   »   [go: up one dir, main page]

BRPI0807799A2 - " derivados de 2-piperazin-1-il-3h-imidazo{4,5-b]piridina". - Google Patents

" derivados de 2-piperazin-1-il-3h-imidazo{4,5-b]piridina".

Info

Publication number
BRPI0807799A2
BRPI0807799A2 BRPI0807799-1A2A BRPI0807799A BRPI0807799A2 BR PI0807799 A2 BRPI0807799 A2 BR PI0807799A2 BR PI0807799 A BRPI0807799 A BR PI0807799A BR PI0807799 A2 BRPI0807799 A2 BR PI0807799A2
Authority
BR
Brazil
Prior art keywords
piperazin
imidazo
compounds
pyridine derivatives
concerned
Prior art date
Application number
BRPI0807799-1A2A
Other languages
English (en)
Inventor
Frans Eduard Janssens
Jerome Emile Georges Guillemont
Francois Maria Sommen
Jean-Francois Bonfanti
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of BRPI0807799A2 publication Critical patent/BRPI0807799A2/pt
Publication of BRPI0807799B1 publication Critical patent/BRPI0807799B1/pt
Publication of BRPI0807799B8 publication Critical patent/BRPI0807799B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0807799A 2007-01-25 2008-01-24 derivados de 2-piperazin-1-il-3h-imidazo[4,5-b]piridina, composição farmacêutica que os compreende, seu processo de preparação e uso BRPI0807799B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07101153 2007-01-25
EP07101153.0 2007-01-25
PCT/EP2008/050818 WO2008090200A2 (en) 2007-01-25 2008-01-24 2- piperazin-1-yl-3h-imidazo[4,5-b]pyridine derivatives

Publications (3)

Publication Number Publication Date
BRPI0807799A2 true BRPI0807799A2 (pt) 2014-06-03
BRPI0807799B1 BRPI0807799B1 (pt) 2021-04-06
BRPI0807799B8 BRPI0807799B8 (pt) 2021-05-25

Family

ID=38179852

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0807799A BRPI0807799B8 (pt) 2007-01-25 2008-01-24 derivados de 2-piperazin-1-il-3h-imidazo[4,5-b]piridina, composição farmacêutica que os compreende, seu processo de preparação e uso

Country Status (18)

Country Link
US (1) US7994173B2 (pt)
EP (1) EP2121683B1 (pt)
JP (1) JP5437814B2 (pt)
KR (1) KR101484027B1 (pt)
CN (1) CN101600717B (pt)
AT (1) ATE522530T1 (pt)
AU (1) AU2008208820B2 (pt)
BR (1) BRPI0807799B8 (pt)
CA (1) CA2671857C (pt)
EA (1) EA016422B1 (pt)
ES (1) ES2372433T3 (pt)
HK (1) HK1136288A1 (pt)
IL (1) IL199986A (pt)
MX (1) MX2009007912A (pt)
PL (1) PL2121683T3 (pt)
UA (1) UA101149C2 (pt)
WO (1) WO2008090200A2 (pt)
ZA (1) ZA200905205B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8716313D0 (en) * 1987-07-10 1987-08-19 Janssen Pharmaceutica Nv 2-(heterocyclylalkyl)imidazopyridines
ES2038532B1 (es) * 1991-05-10 1994-02-16 Espanola Prod Quimicos Procedimiento de preparacion de nuevos derivados de 2-piperacinilbecimidazol.
KR100715344B1 (ko) * 1999-11-23 2007-05-08 얀센 파마슈티카 엔.브이. 기저부 이완을 위한 5ht3 효능제의 용도
TWI225488B (en) 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues

Also Published As

Publication number Publication date
ES2372433T3 (es) 2012-01-19
IL199986A0 (en) 2010-04-15
CN101600717A (zh) 2009-12-09
KR20090101464A (ko) 2009-09-28
CA2671857A1 (en) 2008-07-31
JP5437814B2 (ja) 2014-03-12
EP2121683B1 (en) 2011-08-31
CN101600717B (zh) 2013-03-13
BRPI0807799B1 (pt) 2021-04-06
EP2121683A2 (en) 2009-11-25
WO2008090200A2 (en) 2008-07-31
UA101149C2 (en) 2013-03-11
IL199986A (en) 2013-03-24
AU2008208820B2 (en) 2012-09-20
CA2671857C (en) 2013-11-19
MX2009007912A (es) 2009-07-31
ZA200905205B (en) 2010-09-29
KR101484027B1 (ko) 2015-01-19
HK1136288A1 (pt) 2010-06-25
BRPI0807799B8 (pt) 2021-05-25
US7994173B2 (en) 2011-08-09
ATE522530T1 (de) 2011-09-15
JP2010516740A (ja) 2010-05-20
US20100004260A1 (en) 2010-01-07
EA200970710A1 (ru) 2009-12-30
AU2008208820A1 (en) 2008-07-31
PL2121683T3 (pl) 2012-01-31
EA016422B1 (ru) 2012-04-30
WO2008090200A3 (en) 2008-09-04

Similar Documents

Publication Publication Date Title
MY148429A (en) Novel 1,4-benzothiepin-1,1-dioxide derivatives which are substituted with benzyl groups, method for producing drugs containing said compounds and use thereof
MX2010011047A (es) Derivados de tienopiridonas como activadores de proteina cinasa activada por amp (ampk).
EA201001682A1 (ru) Производные фенил- и бензодиоксинилзамещенных индазолов
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA201001733A1 (ru) Производные тиенопиридона в качестве активаторов амр-активированной протеинкиназы (амрк)
MX2011012337A (es) Nuevos derivados de pirimidina y su uso en el tratamiento de cancer y de otras enfermedades.
TW200833675A (en) Nicotinamide derivatives
EA201170772A1 (ru) Органические соединения
GEP20146146B (en) Pyrrolopyrimidine compounds as inhibitors of cdk4/6
EA201190235A1 (ru) Замещенные 1-цианоэтилгетероциклилкарбоксамидные соединения 750
CY1112429T1 (el) Υποκατεστημενα παραγωγα σουλφοναμιδιου
TW200732323A (en) Organic compounds
ES2368594T3 (es) Derivados sustituidos de ciclohexilmetilo.
JO2770B1 (en) Organic compounds
EA201200471A1 (ru) Простые эфирные производные бициклических гетероарилов
WO2011006935A3 (en) Tetrazole derivatives
BRPI0508724A (pt) derivados do fenilaminoetanol como agonistas do receptor beta2
UY32744A (es) Derivados de 2-carboxamida-7-piperazinil-benzofurano 774
EA201270302A1 (ru) Безводные формы производных пиридина
BR112012009311A2 (pt) composto, composição farmacêutica, e, uso do composto
EA201100502A1 (ru) Гликозидные производные и их применения
DE602007005387D1 (de) Ptors
BRPI0807799A2 (pt) " derivados de 2-piperazin-1-il-3h-imidazo{4,5-b]piridina".
TNSN08242A1 (en) 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof
MX2009005182A (es) Derivados de 2-hidroxi-1,3-diamino-propano.

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 06/04/2021, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/01/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 16A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2758 DE 14-11-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.